Is Tocilizumab a Potential Therapeutic Option for Refractory Unicentric Castleman Disease?

Hematological Oncology - United Kingdom
doi 10.1002/hon.2420
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Unicentric Retroperitoneal Castleman Disease Presenting With Pleural Effusion

Anatomy & Physiology
2017English

Unicentric Retroperitoneal Castleman Disease: Report of 3 Cases

Cumhuriyet Medical Journal
Medicine
2015English

Outcome and Late Complications of Radiotherapy in Patients With Unicentric Castleman Disease

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2006English

Tocilizumab for Steroid Refractory Acute Graft-Versus-Host Disease

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2015English

The Potential Clinical Benefit of Tocilizumab Therapy for Patients With HHV-8-infected AIDS-related Multicentric Castleman Disease: A Case Report and Literature Review

Cureus
2020English

The Emerging Role of Leptin Antagonist as Potential Therapeutic Option for Inflammatory Bowel Disease

International Reviews of Immunology
AllergyImmunology
2013English

Metformin: A Therapeutic Option for Treating Nonalcoholic Fatty Liver Disease

Digestive Diseases and Sciences
PhysiologyGastroenterology
2010English

Is Vitamin D a New Therapeutic Option in Coronary Artery Disease? Overview Data

Cardiovascular Pharmacology: Open Access
2015English

Is Tetrahydrobiopterin a Therapeutic Option in Diabetic Hypertensive Patients?

Integrated Blood Pressure Control
Internal MedicineCardiovascular MedicineCardiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy